Article info

Download PDFPDF
Intestinal ganglioneuromatosis and multiple endocrine neoplasia type 2B: implications for treatment

Authors

  • V V Smith aDepartment of Histopathology, Great Ormond Street Hospital and Institute of Child Health, London, UK, bDepartment of Gastroenterology, Great Ormond Street Hospital and Institute of Child Health, London, UK, cDana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • C Eng aDepartment of Histopathology, Great Ormond Street Hospital and Institute of Child Health, London, UK, bDepartment of Gastroenterology, Great Ormond Street Hospital and Institute of Child Health, London, UK, cDana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • P J Milla aDepartment of Histopathology, Great Ormond Street Hospital and Institute of Child Health, London, UK, bDepartment of Gastroenterology, Great Ormond Street Hospital and Institute of Child Health, London, UK, cDana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  1. Dr V V Smith, Histopathology, Camelia Botnar Laboratories, Great Ormond Street Hospital, Great Ormond Street, London WC1N 3JH, UK.
View Full Text

Citation

Smith VV, Eng C, Milla PJ
Intestinal ganglioneuromatosis and multiple endocrine neoplasia type 2B: implications for treatment

Publication history

  • Accepted January 20, 1999
  • First published July 1, 1999.
Online issue publication 
February 15, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.